Indications and outcomes of heart transplantation in the patient with congenital heart disease

Charles E. Canter

doi:10.1007/978-1-84996-480-7_5

Indications and outcomes of heart transplantation in the patient with congenital heart disease

Charles E. Canter

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

1 Scopus citations

Abstract

The year 2008 marks the fortieth anniversary of the utilization of heart transplantation as therapy for congenital heart disease.1 Since the introduction of cyclosporine-based immunosuppression over 20 years ago,2,3 heart transplantation has evolved from a heroic therapy to a widely applied therapy for patients with congenital heart disease from infancy to adulthood. Within the International Society for Heart and Lung Transplantation (ISHLT) database, patients with congenital heart disease account for 50-75% of the transplants performed in infants <1 year of age; 25-50% of the transplants performed in children 1-10 years of age; and approximately 25% of the transplants performed in adolescents 10-17 years of age (Fig. 5.1).

Original language	English
Title of host publication	Heart Failure in Congenital Heart Disease
Subtitle of host publication	From Fetus to Adult
Publisher	Springer London
Pages	87-108
Number of pages	22
ISBN (Print)	9781849964791
DOIs	https://doi.org/10.1007/978-1-84996-480-7_5
State	Published - 2011

Access to Document

10.1007/978-1-84996-480-7_5

Cite this

@inbook{1071e6cd7b4a4f94bce6fa3ef5b6775b,

title = "Indications and outcomes of heart transplantation in the patient with congenital heart disease",

abstract = "The year 2008 marks the fortieth anniversary of the utilization of heart transplantation as therapy for congenital heart disease.1 Since the introduction of cyclosporine-based immunosuppression over 20 years ago,2,3 heart transplantation has evolved from a heroic therapy to a widely applied therapy for patients with congenital heart disease from infancy to adulthood. Within the International Society for Heart and Lung Transplantation (ISHLT) database, patients with congenital heart disease account for 50-75% of the transplants performed in infants <1 year of age; 25-50% of the transplants performed in children 1-10 years of age; and approximately 25% of the transplants performed in adolescents 10-17 years of age (Fig. 5.1).",

author = "Canter, {Charles E.}",

year = "2011",

doi = "10.1007/978-1-84996-480-7_5",

language = "English",

isbn = "9781849964791",

pages = "87--108",

booktitle = "Heart Failure in Congenital Heart Disease",

publisher = "Springer London",

}

TY - CHAP

T1 - Indications and outcomes of heart transplantation in the patient with congenital heart disease

AU - Canter, Charles E.

PY - 2011

Y1 - 2011

N2 - The year 2008 marks the fortieth anniversary of the utilization of heart transplantation as therapy for congenital heart disease.1 Since the introduction of cyclosporine-based immunosuppression over 20 years ago,2,3 heart transplantation has evolved from a heroic therapy to a widely applied therapy for patients with congenital heart disease from infancy to adulthood. Within the International Society for Heart and Lung Transplantation (ISHLT) database, patients with congenital heart disease account for 50-75% of the transplants performed in infants <1 year of age; 25-50% of the transplants performed in children 1-10 years of age; and approximately 25% of the transplants performed in adolescents 10-17 years of age (Fig. 5.1).

AB - The year 2008 marks the fortieth anniversary of the utilization of heart transplantation as therapy for congenital heart disease.1 Since the introduction of cyclosporine-based immunosuppression over 20 years ago,2,3 heart transplantation has evolved from a heroic therapy to a widely applied therapy for patients with congenital heart disease from infancy to adulthood. Within the International Society for Heart and Lung Transplantation (ISHLT) database, patients with congenital heart disease account for 50-75% of the transplants performed in infants <1 year of age; 25-50% of the transplants performed in children 1-10 years of age; and approximately 25% of the transplants performed in adolescents 10-17 years of age (Fig. 5.1).

UR - http://www.scopus.com/inward/record.url?scp=84889966113&partnerID=8YFLogxK

U2 - 10.1007/978-1-84996-480-7_5

DO - 10.1007/978-1-84996-480-7_5

M3 - Chapter

AN - SCOPUS:84889966113

SN - 9781849964791

SP - 87

EP - 108

BT - Heart Failure in Congenital Heart Disease

PB - Springer London

ER -

Indications and outcomes of heart transplantation in the patient with congenital heart disease

Abstract

Access to Document

Other files and links

Fingerprint

Cite this